MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2016 International Congress

    Metabolic brain changes related to specific cognitive impairment in non-demented Parkinson’s disease patients

    M. Trošt, S. Brezovar, C.C. Tang, D. Eidelberg, N. Zupancic Kriznar, M. Gregoric Kramberger, P. Tomše, Z. Pirtošek (Ljubljana, Slovenia)

    Objective: To measure the expression of the Parkinson's disease related cognitive pattern (PDCP) in 18F-FDG-PET brain images of Parkinson's disease (PD) patients and healthy controls…
  • 2016 International Congress

    Parkinson’s disease patients with onset in right side have a worse cognitive prognosis

    T. Poliakova, I. Zerr, O. Levin (Belgorod, Russia)

    Objective: The our intention was to investigate a dynamics of cognitive decline in patients with different side of onset parkinsonism in view of visual dysfunction…
  • 2016 International Congress

    Visual hallucinations may serve as a possible predictor for Parkinson’s disease dementia

    Y.P. Chang, Y.H. Yang, C.L. Lai, L.M. Liou (Kaohsiung, Taiwan)

    Objective: To observe whether visual hallucinations serve as a predictor of Parkinson's disease dementia. Background: Visual hallucinations (VH) is one of non-motor symptoms in Parkinson's…
  • 2016 International Congress

    Functional connectivity during resting state in Parkinson’s disease patients with and without mild cognitive impairment

    O. Monchi, A. Nagano-Saito, A. Hanganu, S. Jobert, B. Mejia-Constain, C. Degroot, A.L. Lafontaine, H. Chertkow, A. Tam, P. Orban, P. Bellec, O. Monchi (Calgary, AB, Canada)

    Objective: Determine whole brain functional connectivity changes in Parkinson's disease (PD) with mild Cognitive Impairment (MCI), using bootstrap analysis of stable cluster (BASC) method to…
  • 2016 International Congress

    Technology use and impulse control disorders (ICDs) in patients with Parkinson’s disease (PD)

    E.A. Byrd, C.M. Tanner, C.A. Racine, N.B. Galifianakis (San Francisco, CA, USA)

    Objective: To ascertain the prevalence of problematic technology use (Technology-related ICDs, Tech-ICDs) in patients with PD. Background: ICDs are a known complication of PD drugs…
  • 2016 International Congress

    Assessment of cognitive-motor interference during an upper extremity motor task in Parkinson’s disease

    P.J.M. Bank, J. Marinus, J.H. de Groot, J.J. van Hilten, C.G.M. Meskers (Leiden, Netherlands)

    Objective: To assess cognitive-motor interference (CMI) and task prioritization during simultaneous performance of a cognitive task and an upper extremity motor task in Parkinson's disease…
  • 2016 International Congress

    A comparison of self-report and performance-based balance measures to predict recurrent falls in people with Parkinson’s disease: A cohort study

    L.R.S. Almeida, G.T. Valenca, N.N. Negreiros, E.B. Pinto, J. Oliveira-Filho (Salvador, Brazil)

    Objective: To compare the accuracy of the Activities-specific Balance Confidence Scale (ABC) and Falls Efficacy Scale-International (FES-I) with the Berg Balance Scale (BBS), Dynamic Gait…
  • 2016 International Congress

    Improvement of levodopa induced foot dystonia with 60 Hz frequency subthalamic- deep brain stimulation

    J.P. Battista, R.A. Ramdhani (New York, NY, USA)

    Objective: To present a case of levodopa induced foot dystonia that improved with 60Hz frequency subthalamic- deep brain stimulation. Background: Deep Brain Stimulation is an…
  • 2016 International Congress

    Duration of levodopa treatment and prevalence of osteoporosis in patients with Parkinson’s disease

    S.H. Guptha (Peterborough, United Kingdom)

    Objective: To assess whether the prevalence of osteoporosis increases with the duration of levodopa treatment in patients with Parkinson's disease. Background: Patients with Parkinson's disease…
  • 2016 International Congress

    Long-term effects of levodopa/carbidopa intestinal gel infusion in advanced Parkinson’s disease patients: Dutch multicenter retrospective cohort study

    H.R. Moes, J. Groenendal-Laurensse, M. Drent, G. Tissingh, T. van Laar (Groningen, Netherlands)

    Objective: To determine the long-term outcomes of levodopa/carbidopa intestinal gel infusion (LCIG) in advanced Parkinson's disease (PD) patients. Background: LCIG was introduced in the Netherlands…
  • « Previous Page
  • 1
  • …
  • 364
  • 365
  • 366
  • 367
  • 368
  • …
  • 425
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley